# Perrigo Company PLC (PRGO) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/PRGO
## Company Profile
- Ticker: PRGO
- Exchange: NYSE
- Sector: Biopharma
- Location: Ireland
## Stock Data
- Close: 12.54 USD
- Market cap: 1447326874.2 USD
- Last updated: 2026-08-06
## Business Overview
### Consumer Self-Care Portfolio
Perrigo is a global provider of over-the-counter health and wellness products intended for conditions that consumers can prevent or manage themselves. Its portfolio spans branded and store-brand medicines and self-care products sold through major retail and pharmacy channels.
### Consumer and Specialty Care Operations
The company serves broad everyday-health categories while also operating a Specialty Care portfolio that includes brands such as Compeed, Opill and ellaOne. Opill gives Perrigo a differentiated presence in women’s health as an over-the-counter daily oral contraceptive in the United States.
### Portfolio Simplification
Perrigo is narrowing its focus around core self-care categories and has divested its Dermacosmetics business. The strategy is intended to create a more focused operating structure and concentrate resources on brands and categories where the company has consumer-health scale.
## Why The Stock Is Moving

Following the latest company update, “Perrigo Reports Second Quarter 2026 Financial Results From Continuing Operations”, PRGO closed up 23.1% at $13.27 on Aug 5, 2026. The move occurred in the trading session associated with this earnings update.

## Future Catalysts

- Perrigo's story is mostly operational and portfolio-driven, with Project Energize and the Dermacosmetics divestiture doing most of the work. The question is whether the business can keep simplifying itself while still extracting value from the self-care and consumer health franchises.

## Recent News
- 2026-08-05 10:30 EST — [Perrigo Reports Second Quarter 2026 Financial Results From Continuing Operations](https://biopharmsignal.com/news/PRGO/perrigo-reports-second-quarter-2026-financial-results-from-continuing-operations-0a57cffb) — Source: Perrigo Company PLC
- 2026-07-30 12:30 EST — [Perrigo Announces Quarterly Dividend](https://biopharmsignal.com/news/PRGO/perrigo-announces-quarterly-dividend-a2e51c0e) — Source: Perrigo Company PLC
- 2026-07-29 12:30 EST — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922) — Source: Perrigo Company PLC
- 2026-07-22 12:30 EST — [Perrigo to Release Second Quarter 2026 Financial Results on August 5, 2026](https://biopharmsignal.com/news/PRGO/perrigo-to-release-second-quarter-2026-financial-results-on-august-5-2026-ff2ea2a5) — Source: Perrigo Company PLC
- 2026-06-30 20:25 EST — [Perrigo Announces Appointment of Two New Independent Directors to Board](https://biopharmsignal.com/news/PRGO/perrigo-announces-appointment-of-two-new-independent-directors-to-board-47cee7b5) — Source: Perrigo Company PLC